Jiangzhong Pharmaceutical controlling shareholder completes share increase plan

Jiangzhong Pharmaceutical announced that its controlling shareholder, China Resources Jiangzhong Pharmaceutical Group Co., Ltd., completed its share increase plan between October 22, 2024, and October 21, 2025. During this period, a total of 2,844,550 shares were acquired through the Shanghai Stock Exchange's centralized bidding system, representing 0.45% of the company's total share capital. The total value of these acquisitions was 61,292,218.30 yuan (excluding transaction fees), falling within the previously announced target of 0.6 billion yuan to 1.2 billion yuan.

Following this increase, China Resources Jiangzhong Pharmaceutical Group Co., Ltd. now holds 273,938,021 shares, accounting for 43.14% of Jiangzhong Pharmaceutical's total share capital. This action aligns with the "Securities Law" and other regulations, qualifying for an exemption from tender offer requirements under the "Measures for the Administration of the Acquisition of Listed Companies."

Additionally, Jiangzhong Pharmaceutical will host an online performance briefing on October 30, 2025, to discuss its Q3 2025 results. This event will allow investors to interact with company management regarding the latest financial performance.